DexCom, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $1.26B | ↑+13.1% | $267M | ↑+76.2% | 25.6% |
| 2025-09-30 | $1.21B | ↑+21.6% | $284M | ↑+110.8% | 20.1% |
| 2025-06-30 | $1.16B | ↑+15.2% | $180M | ↑+25.3% | 18.4% |
| 2025-03-31 | $1.04B | ↑+12.5% | $105M | ↓-28.0% | 12.9% |
| 2024-12-31 | $1.11B | ↑+7.6% | $152M | ↓-40.8% | 17.0% |
| 2024-09-30 | $994M | ↑+2.0% | $135M | ↑+11.5% | 15.3% |
| 2024-06-30 | $1.00B | ↑+15.3% | $144M | ↑+23.8% | 15.7% |
| 2024-03-31 | $921M | ↑+24.2% | $146M | ↑+201.2% | 11.0% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 65 quarters
margin trajectory tells the operating-leverage storyGo deeper
DXCM Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyDXCM Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics